Hematology/Oncology

Top Story

Vanderbilt University Medical Center names executive vice president for research

Vanderbilt University Medical Center names executive vice president for research
May 3, 2016

Jennifer Pietenpol, PhD, has been named executive vice president for research at Vanderbilt University Medical Center.

Pietenpol will continue to serve as director of Vanderbilt-Ingram Cancer Center, a position she has held since 2007.

Radiopaque bead treatment at Mount Sinai ‘potential game-changer’ for hepatocellular carcinoma

May 3, 2016
An estimated 746,000 deaths occur annually from liver cancer worldwide.Few surgical options are considered beneficial in patients with intermediate- or advanced-stage…
In the Journals

Trastuzumab underutilized among older, black women with HER-2–positive breast cancer

May 3, 2016
Approximately half of women aged 65 years or older with early-stage, HER-2–positive breast cancer did not receive targeted therapy with trastuzumab, according to…
Meeting News Coverage

Nucleos(t)ide therapy for HBV does not increase risk for all cancers

May 3, 2016
BARCELONA — New data presented at the International Liver Congress showed patients with chronic hepatitis B virus infection who receive long-term treatment with…
At IssueVideo

VIDEO: Progress in MRD testing poised to further improve patient outcomes in myeloma

May 3, 2016
C. Ola Landgren, MD, PhD, chief of the myeloma service at the Memorial Sloan Kettering Cancer Center in New York City, discusses the advances in outcomes in multiple…
More News Headlines »
CME Video

Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-line Therapy

This activity is supported by an independent educational grant from Merck & Co., Inc.

The incidence of melanoma is continuing to increase worldwide. In recent years, the treatment landscape for this…
More »
Video

VIDEO: Genomic assays have role in determining need for adjuvant chemotherapy

April 29, 2016
More »
Featured
CME

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty-five percent of lung cancers are non-small…
More »
Current Issues
View the Current Issue
HemOnc Today